EQT Life Sciences-Backed AgomAb Falls After $200 Million IPO

by | February 9, 2026 8:20 am | Indian Stocks, Market, News

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company backed by EQT Life Sciences, closed 8.4% below its IPO price in its trading debut Friday after the firm raised $200 million in a listing.